Liqin Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liqin Zhang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Mo Dong
The First Affiliated Hospital of Wannan Medical College,Yijishan Hospital,2 Zheshan West Road, Wuhu 241000,China
2 shared publicationsYuancheng Xiong
The First Affiliated Hospital of Wannan Medical College,Yijishan Hospital,2 Zheshan West Road, Wuhu 241000,China
2 shared publicationsChao Xie
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
1 shared publicationEmmanuel Mensah
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China
1 shared publication- Hui Yang
Anhui Province Key Laboratory of Non-coding RNA Basie and Clinical Transformation, Tissue Bank, Central Laboratory, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) , Wuhu, Anhui
1 shared publication Jun Liu
Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui 241001, China
1 shared publication
Latest Publications
- Open Access
- 22 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1832417
Case Report: Pulmonary Mycobacterium avium complex mimicking recurrent tuberculosis in a patient with suspected pneumoconiosis and destroyed lung diagnosed by bronchoalveolar lavage fluid targeted next-generation sequencing
A 42-year-old man, a coal miner with a history of pulmonary tuberculosis, dust exposure, and suspected pneumoconiosis, presented with cough, purulent sputum, and intermittent fever for more than 1 month. Routine sputum bacterial and fungal cultures, as well as acid-fast bacilli smears, were persistently negative. Chest computed tomography revealed markedly distorted bilateral lung architecture with patchy and nodular opacities, multiple irregular cavitary lesions, emphysema, pulmonary bullae, and mediastinal lymphadenopathy. To obtain a definitive diagnosis, a bronchoscopy was safely performed under strict asepsis and painless anesthesia. The procedure showed inflammatory bronchial changes and narrowing of the right upper lobe posterior and dorsal segmental bronchi due to external compression. Targeted next-generation sequencing (tNGS) of the bronchoalveolar lavage fluid on the MGI VisionSeq 1000 platform detected Mycobacterium avium complex (349 sequence reads, 53.4% relative abundance). The patient’s condition improved rapidly following a targeted multidrug regimen (clarithromycin, rifampicin, ethambutol, and amikacin) combined with supportive pneumoconiosis care. This case highlights the vital role of tNGS in differentiating nontuberculous mycobacterial disease from recurrent tuberculosis in patients with complex structural lung damage, enabling timely and precise intervention.
- 22 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1832417
Open AccessCase Report: Pulmonary Mycobacterium avium complex mimicking recurrent tuberculosis in a patient with suspected pneumoconiosis and destroyed lung diagnosed by bronchoalveolar lavage fluid targeted next-generation sequencing
A 42-year-old man, a coal miner with a history of pulmonary tuberculosis, dust exposure, and suspected pneumoconiosis, presented with cough, purulent sputum, and intermittent fever for more than 1 month. Routine sputum bacterial and fungal cultures, as well as acid-fast bacilli smears, were persistently negative. Chest computed tomography revealed markedly distorted bilateral lung architecture with patchy and nodular opacities, multiple irregular cavitary lesions, emphysema, pulmonary bullae, and mediastinal lymphadenopathy. To obtain a definitive diagnosis, a bronchoscopy was safely performed under strict asepsis and painless anesthesia. The procedure showed inflammatory bronchial changes and narrowing of the right upper lobe posterior and dorsal segmental bronchi due to external compression. Targeted next-generation sequencing (tNGS) of the bronchoalveolar lavage fluid on the MGI VisionSeq 1000 platform detected Mycobacterium avium complex (349 sequence reads, 53.4% relative abundance). The patient’s condition improved rapidly following a targeted multidrug regimen (clarithromycin, rifampicin, ethambutol, and amikacin) combined with supportive pneumoconiosis care. This case highlights the vital role of tNGS in differentiating nontuberculous mycobacterial disease from recurrent tuberculosis in patients with complex structural lung damage, enabling timely and precise intervention.
- Open Access
- 3 November 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1681411
Burden of chronic obstructive pulmonary disease in Ghana and globally from 1990 to 2021, with projections through 2050: a systematic analysis based on the Global Burden of Disease Study 2021
Objective: To assess the burden of chronic obstructive pulmonary disease (COPD) in Ghana within a global context, analyze temporal trends and risk factor attribution from 1990 to 2021, and project the future burden through 2050. Study design: Secondary analysis of Global Burden of Disease (GBD) 2021 data, using statistical modeling to evaluate trends in COPD prevalence, incidence, mortality, disability-adjusted life years (DALYs), and attributable risk factors. Future projections were generated using Bayesian Age-Period-Cohort (BAPC) modeling. Data source: GBD 2021 study, providing standardized estimates for 369 diseases across 204 countries and territories. Main outcome measures: COPD-related deaths, prevalence, incidence, DALYs, age-standardized rates (ASRs), risk factor attribution, percentage change, age-specific death rates, and projections to 2050. Results: From 1990 to 2021, Ghana experienced a 157% increase in COPD deaths (from 693 to 1,782), compared to a 49% global increase. Ghana's age-standardized death rate (ASDR) declined by only 7%, far below the global reduction of 37%. COPD prevalence in Ghana tripled, rising from 0.1 to 0.3 million, while incidence increased by 215% and DALYs by 171%. Globally, DALYs rose by 40% over the same period. In Ghana, household air pollution from solid fuel use accounted for 40% of COPD deaths, followed by ambient air pollution (25%). Globally, particulate matter pollution (41%) and smoking (36%) were dominant. Projections show continued increases in prevalence and incidence, particularly among adults aged 40–64, with plateauing DALYs and declining ASDR by the 2040s. Mortality increases sharply after age 60, with higher burden among males. Cohort analysis reveals rising mortality risk among those born after 1960. Conclusion: Despite modest ASDR reductions, Ghana's absolute COPD burden is increasing, driven by preventable risk factors such as household air pollution. These findings highlight the need for targeted interventions, including clean cook-stove programs, improved air quality monitoring, and expanded access to spirometry and early screening. Such efforts are essential to reduce COPD-related morbidity and mortality and advance Sustainable Development Goal (SDG) 3.4.
- 3 November 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1681411
Open AccessBurden of chronic obstructive pulmonary disease in Ghana and globally from 1990 to 2021, with projections through 2050: a systematic analysis based on the Global Burden of Disease Study 2021
Objective: To assess the burden of chronic obstructive pulmonary disease (COPD) in Ghana within a global context, analyze temporal trends and risk factor attribution from 1990 to 2021, and project the future burden through 2050. Study design: Secondary analysis of Global Burden of Disease (GBD) 2021 data, using statistical modeling to evaluate trends in COPD prevalence, incidence, mortality, disability-adjusted life years (DALYs), and attributable risk factors. Future projections were generated using Bayesian Age-Period-Cohort (BAPC) modeling. Data source: GBD 2021 study, providing standardized estimates for 369 diseases across 204 countries and territories. Main outcome measures: COPD-related deaths, prevalence, incidence, DALYs, age-standardized rates (ASRs), risk factor attribution, percentage change, age-specific death rates, and projections to 2050. Results: From 1990 to 2021, Ghana experienced a 157% increase in COPD deaths (from 693 to 1,782), compared to a 49% global increase. Ghana's age-standardized death rate (ASDR) declined by only 7%, far below the global reduction of 37%. COPD prevalence in Ghana tripled, rising from 0.1 to 0.3 million, while incidence increased by 215% and DALYs by 171%. Globally, DALYs rose by 40% over the same period. In Ghana, household air pollution from solid fuel use accounted for 40% of COPD deaths, followed by ambient air pollution (25%). Globally, particulate matter pollution (41%) and smoking (36%) were dominant. Projections show continued increases in prevalence and incidence, particularly among adults aged 40–64, with plateauing DALYs and declining ASDR by the 2040s. Mortality increases sharply after age 60, with higher burden among males. Cohort analysis reveals rising mortality risk among those born after 1960. Conclusion: Despite modest ASDR reductions, Ghana's absolute COPD burden is increasing, driven by preventable risk factors such as household air pollution. These findings highlight the need for targeted interventions, including clean cook-stove programs, improved air quality monitoring, and expanded access to spirometry and early screening. Such efforts are essential to reduce COPD-related morbidity and mortality and advance Sustainable Development Goal (SDG) 3.4.
- Open Access
- 24 February 2025
- Published by Elsevier in Phytomedicine
- Vol. 139, 156563
Exploring the therapeutic potential of HAPC in COVID-19-induced acute lung injury
- 24 February 2025
- Published by Elsevier in Phytomedicine
- Vol. 139, 156563
Open AccessExploring the therapeutic potential of HAPC in COVID-19-induced acute lung injury
- 1 December 2021
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1876 (2) , 188629
Targeting ion channels for the treatment of lung cancer
- 1 December 2021
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1876 (2) , 188629
Targeting ion channels for the treatment of lung cancer
- Open Access
- 19 March 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (11) , e24987
Primary pulmonary lymphoepithelioma-like carcinoma
Rationale: Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare subtype of non-small cell lung cancer (NSCLC). It is predominantly reported in East Asia and currently there is no standard treatment for this disease. We report a case of stage IV PPLELC that achieved pathological complete response (pCR) by neoadjuvant treatment. Patient concerns: The patient was a 46-year-old male who developed hemoptysis for about 20 ml of volume accompanied by cough and sputum after physical labor. Diagnoses: Contrast enhanced chest CT scanning showed occupation of left lower hilar area and left pleural effusion. Combined with medical history and auxiliary examination, the patient was formally diagnosed stage IV lymphoepithelioma-like carcinoma of the left lower lung (T3N0M1a pleura). Interventions: The patient was given Sintilimab combined with gemcitabine + nedaplatin chemotherapy (GP) regimen for four cycles with 3 weeks as a cycle, supplemented with antiemetics and stomach protection drugs to reduce chemotherapy-related side effects. Outcomes: After 4 cycles of treatment, the patient's left lung lesion has been markedly reduced and the left pleural effusion has also been significantly absorbed. Remarkably, surgical biopsies found no cancer cells in the lesion site and postoperative pathology showed complete pathological remission (pCR). Lessons: We reported a case of PPLELC that is sensitive to neoadjuvant treatment, showing excellent effectiveness and safety and achieving pCR.
- 19 March 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (11) , e24987
Open AccessPrimary pulmonary lymphoepithelioma-like carcinoma
Rationale: Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare subtype of non-small cell lung cancer (NSCLC). It is predominantly reported in East Asia and currently there is no standard treatment for this disease. We report a case of stage IV PPLELC that achieved pathological complete response (pCR) by neoadjuvant treatment. Patient concerns: The patient was a 46-year-old male who developed hemoptysis for about 20 ml of volume accompanied by cough and sputum after physical labor. Diagnoses: Contrast enhanced chest CT scanning showed occupation of left lower hilar area and left pleural effusion. Combined with medical history and auxiliary examination, the patient was formally diagnosed stage IV lymphoepithelioma-like carcinoma of the left lower lung (T3N0M1a pleura). Interventions: The patient was given Sintilimab combined with gemcitabine + nedaplatin chemotherapy (GP) regimen for four cycles with 3 weeks as a cycle, supplemented with antiemetics and stomach protection drugs to reduce chemotherapy-related side effects. Outcomes: After 4 cycles of treatment, the patient's left lung lesion has been markedly reduced and the left pleural effusion has also been significantly absorbed. Remarkably, surgical biopsies found no cancer cells in the lesion site and postoperative pathology showed complete pathological remission (pCR). Lessons: We reported a case of PPLELC that is sensitive to neoadjuvant treatment, showing excellent effectiveness and safety and achieving pCR.